Experts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.
Leukemia and Lymphoma
As multiple myeloma treatment improvements continue, it’s important for managed care executives to get out in front of these 10 changes on the horizon.
Unique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.
Moffitt Cancer Center expert shares her thinking on managing chemotherapy-related side effects.
Just as cancer takes many forms, so does genetic testing. Here’s what you need to know.
Key takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.
One study seeks to understand the underlying causes of racial and ethnic disparities in cancer survival. The results may be surprising.
As genomics continues to evolve, here are five things to know about genetic testing and counseling.
With the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.
CAR-T therapies have high price tags so it’s important to understand your patient population and budget impact.